HELIOS Hospital Erfurt, Department of diagnostic and interventional Radiology and Neuroradiology, Nordhaeuser Str. 74, 99089 Erfurt, Germany.
Eur J Radiol. 2013 Mar;82(3):504-7. doi: 10.1016/j.ejrad.2012.10.030. Epub 2012 Dec 6.
To evaluate the impact of endovascular embolisation therapy in men with erectile impotence due to veno-occlusive dysfunction.
We retrospectively evaluated 29 patients with a history of erectile impotence due to veno-oclusive dysfunction confirmed by pharmacocavernosometry and cavernosography. All underwent endovascular embolisation therapy over transfemoral approach. After positioning the catheter system at the target level heights, embolisation with N-butyl-2-cyanoacrylate (Histoacryl(®)) was performed. Technical and clinical success as well as major and minor complications were evaluated.
All procedures were performed without any major or minor events. Complication rate was 0%. Technical success was achieved in 27/29 (93.1%). Two patients failed for anatomical reasons. Overall clinical success was achieved in 24/27 (88.8%) patients with recovering from E1 (poor tumescense/no rigidity) to E4 (good tumescence/intermediate rigidity) in 11/27 (40.7%), E1 to E5 in 8/27 (tumescence/normal rigidity) (29.6%) and E1 to E3 (good tumescence/poor rigidity) in 5/27 (18.5%) respectively. 3/27 (11.1%) received no change in ED severity score.
Endovascular embolisation therapy for veno-occlusive dysfunction in erectile impotence is a safe and effective therapeutic option with low complication rate and highly technical and clinical success rates.
评估血管内栓塞治疗静脉闭塞性功能障碍导致的男性勃起功能障碍的效果。
我们回顾性评估了 29 例经药物海绵体测压和海绵造影证实静脉闭塞性功能障碍导致勃起功能障碍的患者。所有患者均经股动脉入路行血管内栓塞治疗。将导管系统定位在目标高度后，用 N-丁基-2-氰基丙烯酸酯（Histoacryl（®））进行栓塞。评估技术和临床成功率以及主要和次要并发症。
所有手术均无任何重大或轻微事件发生。并发症发生率为 0%。27/29 例（93.1%）达到技术成功。2 例因解剖原因失败。24/27 例（88.8%）患者获得总体临床成功，其中 11/27 例（40.7%）从 E1（勃起不佳/无硬度）恢复至 E4（勃起良好/中度硬度），8/27 例（29.6%）从 E1 恢复至 E5（勃起/正常硬度），5/27 例（18.5%）从 E1 恢复至 E3（勃起良好/轻度硬度）。3/27 例（11.1%）患者勃起功能严重程度评分无变化。
血管内栓塞治疗静脉闭塞性功能障碍导致的勃起功能障碍是一种安全有效的治疗选择，并发症发生率低，技术和临床成功率高。
